Viewing nowCombinationTwinheat Tablets 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kips Biopharma Co., Ltd.

MFDS item code 201605774 · Approved 2016.09.30 · Insurance code 693201740
Treatment of essential hypertension not controlled with monotherapy
This drug is used for patients with essential hypertension who do not achieve adequate blood pressure control with either amlodipine or telmisartan alone. It effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This drug should not be used in pregnant women, particularly in the second and third trimesters, as it may pose a serious risk to the fetus. Once pregnancy is confirmed, the medication should be discontinued immediately. Patients with hypersensitivity to this drug or certain heart, liver, or kidney conditions, as well as women who are pregnant or breastfeeding, should not take this medication. Special caution is required for patients with impaired liver or kidney function, and dosage adjustments may be necessary. Patients with other hypertension-related conditions or specific heart valve diseases should also use this drug cautiously. Side effects such as dizziness, edema, and hypotension may frequently occur, and medical consultation should be sought if symptoms occur. If blood pressure becomes too low or serious side effects are suspected, immediate medical attention should be sought. This drug can interact with other medications, so patients taking other drugs must inform their doctor or pharmacist. Frequent monitoring of serum potassium levels is necessary, especially when used in combination with potassium-rich drugs or diuretics. This drug is not recommended for children as its safety and efficacy have not been sufficiently established. Elderly patients may be more sensitive to this medication, and caution is advised during administration. In cases of overdose, symptoms such as hypotension, dizziness, and heart abnormalities may occur, and immediate medical attention should be sought. This medication should be stored out of reach of children and kept in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container that protects it from light, in a temperature range of 1 to 30 degrees Celsius. This storage method helps maintain the drug's efficacy and prevents degradation.
Biconvex oval double-layer tablet in white and light gray color
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.